According to a groundbreaking clinical trials program, which targeted an experimental treatment directly to the brain, offers hope that the damaged cells can be restored in Parkinson’s disease. The study examined whether improving the levels of Glial Cell Line Derived Neurotrophic Factor (GDNF), a naturally-occurring growth factor, in patients with Parkinson’s disease can renew dying dopamine brain cells and reverse the condition.
Parkinson’s News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.